Universe Pharmaceuticals INC Interest Expense
Universe Pharmaceuticals INC (UPC) reported Interest Expense of $289.38 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-01-29
| Period end | Interest Expense 6 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | $289.38M 20-F · filed 2026-01-29 | ||
| 2024-09-30 | $304.52M 20-F · filed 2026-01-29 | ||
| 2023-09-30 | $190.18M 20-F · filed 2026-01-29 | $156.79K 20-F · filed 2024-01-30 | |
| 2023-03-31 | $74.57K 6-K · filed 2023-08-31 | ||
| 2022-09-30 | $162.40K 20-F · filed 2024-01-30 | ||
| 2022-03-31 | $88.39K 6-K · filed 2023-08-31 | ||
| 2021-09-30 | $101.60K 20-F · filed 2024-01-30 | ||
| 2021-03-31 | $46.67K 6-K · filed 2022-08-16 | ||
| 2020-09-30 | $123.76K 20-F · filed 2023-02-10 | ||
| 2019-09-30 | $129.27K 20-F · filed 2022-01-31 |